<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02654158</url>
  </required_header>
  <id_info>
    <org_study_id>2013Pro234.EKZY</org_study_id>
    <nct_id>NCT02654158</nct_id>
  </id_info>
  <brief_title>Phase IV Trial,The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Acute Upper Respiratory Infection</brief_title>
  <official_title>Phase IV Trial,The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Acute Upper Respiratory Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guangzhou Yipinhong Pharmaceutical CO.,LTD</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guangzhou Yipinhong Pharmaceutical CO.,LTD</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Phase IV trial,Single-arm, multi-centre clinical trial to assess the efficacy and safety of
      Fuganlin Oral Liquid in children with acute upper respiratory infection
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Low-dose group of Fuganlin Oral Liquid:dosage from 5 to 10 ml;

      High-dose group of Fuganlin Oral Liquid:dosage from 10 to 20 ml;

      Treatment for 1 week.Patients who were recovered within 1 week can withdrawal at any time.

      Research purpose:

        1. Evaluate the safety and efficacy of Fuganlin oral Liquid when expanding the designated
           indications(Qi deficiency wind-heat syndrome to wind-heat syndrome) .

        2. Explore the relationship between elevated white blood cells and efficacy, age and
           efficacy, dose and efficacy,While treating with Fuganlin oral Liquid in children with
           acute respiratory infection.

        3. Observe the antiviral and immunomodulatory effects of Fuganlin oral Liquid.

        4. Provide data to support the clinical medicine guidelines and labels amendment of
           Fuganlin oral Liquid.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Actual">May 2017</completion_date>
  <primary_completion_date type="Actual">May 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of cold symptoms</measure>
    <time_frame>Defined as the time from the onset of the cold to the time achieve a cold cure standard,time average 1 to 7 days</time_frame>
    <description>Cold diagnostic criteriaï¼š
Nasal congestion, runny nose, sneezing, itchy throat, or pain, cough
The chills, fever, no sweat or less sweat, headache, limb sour
The total numbers of normal or low white blood cells, neutropenia, relative increase in lymphocytes.
Cold cure criteria:
Fever, aversion to wind individual symptoms disappeared
Nasal congestion, runny nose, sore throat, cough individual symptoms disappeared</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">2400</enrollment>
  <condition>Acute Upper Respiratory Infection</condition>
  <arm_group>
    <arm_group_label>Low-dose of Fuganlin Oral Liquid</arm_group_label>
    <description>oral
less than 1 years old: 5mL each time and three times a day
1~3 years old: 10mL each time and three times a day
4~6 years old: 10mL each time and four times a day
7~12 years old: 10mL each time and five times a day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High-dose of Fuganlin Oral Liquid</arm_group_label>
    <description>oral
less than 1 years old: 10mL each time and three times a day
1~3 years old: 20mL each time and three times a day
4~6 years old: 20mL each time and four times a day
7~12 years old: 20mL each time and five times a day</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Low-dose of Fuganlin Oral Liquid</intervention_name>
    <description>less than 1 years old: 5mL each time and three times a day
1~3 years old: 10mL each time and three times a day
4~6 years old: 10mL each time and four times a day
7~12 years old: 10mL each time and five times a day</description>
    <arm_group_label>Low-dose of Fuganlin Oral Liquid</arm_group_label>
    <other_name>No other names</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>High-dose of Fuganlin Oral Liquid</intervention_name>
    <description>less than 1 years old: 10mL each time and three times a day
1~3 years old: 20mL each time and three times a day
4~6 years old: 20mL each time and four times a day
7~12 years old: 20mL each time and five times a day</description>
    <arm_group_label>High-dose of Fuganlin Oral Liquid</arm_group_label>
    <other_name>No other names</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Children aged 1 to 12 years old with acute upper respiratory infection
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients diagnosed as acute upper respiratory infection.

          2. Patients with acute upper respiratory infection diagnosed as Tradition Chinese
             Medicine syndrome qi deficiency wind-heat.

          3. Patients aged 1 to 12 years old.

          4. Parents or guardians agreed to participate this study and signed the informed consent.

        Exclusion Criteria:

          1. Patients whose total numbers of white blood cells around above1.3ULN.

          2. Patients diagnosed as suppurative tonsillitis, otitis media, bronchitis and other
             airway.

          3. Patients allergic to the test drug.

          4. Serious cardiovascular, liver,kidney and other primary systemic diseases.

          5. Patients should not be included in group according to investigator's evaluation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Li xinmin, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>The First Affiliated Hospital of Tianjing University of Traditional Chinese Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Chang ke, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chengdu University of Traditional Chinese Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Meng qingping, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zhengzhou Children's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tao lei, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Huanggang Maternal and Child Health Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ding ying, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital of The First Affiliated Hospital of Henan College of Traditional Chinese Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xiang xixiong, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hubei Hospital of Traditional Chinese Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cheng ji, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Second Affiliated Hospital of Wenzhou Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ying yong, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Affiliated Shanghai Children's Medical Center of Shanghai Jiaotong University School of medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Liu changshan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Second Hospital of Tianjin Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mou qinghui, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jinan Children's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Liu yulin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zhongshan boai Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wang lisheng, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shenzhen Children's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zhao deyu, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Affiliated Nanjing Children's Hospital of Nanjing Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Du yonggang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Changzhi People's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Su baoling, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Affiliated Heji Hospital of Changzhi Medical College</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Qing yanhong, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Affiliated Hospital of Shanxi College of Traditional Chinese medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cheng zhimin, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Affiliated Children's Hospital of Zhejiang University School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lin yan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chengdu Women and Children's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xu youjia, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Guangdong Provincial Hospital of Traditional Chinese Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zhang mingying, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Shunyi Hospital of China Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Guangdong Provincial Hospital of Traditional Chinese Medicine</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>440100</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 11, 2016</study_first_submitted>
  <study_first_submitted_qc>January 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 13, 2016</study_first_posted>
  <last_update_submitted>May 18, 2017</last_update_submitted>
  <last_update_submitted_qc>May 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>acute upper respiratory infection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Respiratory Tract Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

